Universitatsklinikum des Saarlandes ( Site 1513)
Homburg, Saarland, Germany
University hospital in Homburg, Saarland
Kirrberger Str. 100, 66421 Homburg
About Universitatsklinikum des Saarlandes ( Site 1513)
"Das Universitätsklinikum des Saarlandes (UKS) ist mit 30 Kliniken und 20 Instituten das medizinische Hochleistungszentrum der Großregion und bietet international vernetzte Spitzenforschung. Jedes Jahr werden über 50.000 Patienten stationär und über 200.000 ambulant versorgt. Als einer der größten Arbeitgeber und Ausbilder des Saarlandes beschäftigen wir über 5 000 Beschäftigte, darunter u. a. 2 000 Pflegekräfte, rund 600 Ärztinnen und Ärzte und über 600 Auszubildende. An der Medizinischen Fakultät des Saarlandes studieren rund 2.000 Studentinnen und Studenten der Fächer Human- und Zahnmedizin, Human- und Molekularbiologie sowie Bioinformatik."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)
2
Eli Lilly and Company
1
Synta Pharmaceuticals Corp.
1
Clinical Trials at Universitatsklinikum des Saarlandes ( Site 1513)
During the past decade, Universitatsklinikum des Saarlandes ( Site 1513) conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC
2013-04-01
2015-12-01
Terminated
696
Study of Sotatercept in Newly Diagnosed Intermediate- and High-Risk PAH Participants (MK-7962-005/A011-13)
2022-03-18
2028-08-31
Recruiting
662
A Study of Sotatercept in Participants With PAH WHO FC III or FC IV at High Risk of Mortality (MK-7962-006/ZENITH)
2021-12-01
2026-12-31
Recruiting
200
A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer
2022-10-04
2032-03-15
Recruiting
6,000
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Universitatsklinikum des Saarlandes ( Site 1513)
According to Clinical.Site data, the most researched conditions in "Universitatsklinikum des Saarlandes ( Site 1513)" are
"Pulmonary Arterial Hypertension" (2 trials), "Breast Neoplasms" (1 trials), "Non-Small-Cell Lung Adenocarcinoma" (1 trials), "Non-small Cell Lung Cancer Metastatic" (1 trials) and "Non-small Cell Lung Cancer Stage IIIB" (1 trials). Many other conditions were trialed in "Universitatsklinikum des Saarlandes ( Site 1513)" in a lesser frequency.
Clinical Trials Intervention Types at Universitatsklinikum des Saarlandes ( Site 1513)
Most popular intervention types in "Universitatsklinikum des Saarlandes ( Site 1513)" are "Drug" (4 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Sotatercept" (2 trials), "Anastrozole" (1 trials), "Docetaxel" (1 trials) and "Exemestane" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Universitatsklinikum des Saarlandes ( Site 1513)
The vast majority of trials in "Universitatsklinikum des Saarlandes ( Site 1513)" are
4 trials for "All" genders.
Clinical Trials Status at Universitatsklinikum des Saarlandes ( Site 1513)
Currently, there are NaN active trials in "Universitatsklinikum des Saarlandes ( Site 1513)".
undefined are not yet recruiting,
3 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Universitatsklinikum des Saarlandes ( Site 1513),
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Universitatsklinikum des Saarlandes ( Site 1513), 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".